Plcg2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein
|1=Phospholipase C gamma-2
|symbol=PLCG2
|alias=PLC-γ2
|uniprot=P19174
|molecular_weight=150 kDa
|protein_family=Phospholipase C family
|function=Signal transduction, calcium signaling, immune function
|diseases=Alzheimer's Disease, Parkinson's Disease, ALS, Autoimmune disorders
}}
PLCG2 (Phospholipase C Gamma-2) encodes phospholipase C gamma-2, a key enzyme in intracellular signal transduction. PLCG2 hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two important second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). These molecules regulate calcium release and protein kinase C activation, respectively. PLCG2 plays critical roles in immune cell signaling, neuronal function, and is implicated in neurodegenerative diseases.
PLCG2 is a 150 kDa enzyme with a multi-domain architecture:
| Domain | Position | Function |
|---|---|---|
| PH domain | N-terminal | Membrane targeting, PIP2 binding |
| EF-hand domain | N-terminal | Calcium binding |
| X domain | Central | Catalytic core |
| Y domain | Central | Catalytic core |
| C2 domain | Central | Lipid binding |
| SH2 domains (x2) | C-terminal | Tyrosine phosphorylation recognition |
| SH3 domain | C-terminal | Proline-rich protein binding |
PLCG2 catalyzes:
| Process | Description |
|---|---|
| Calcium signaling | IP3-mediated Ca²⁺ release |
| PKC activation | DAG activates PKC isoforms |
| Transcriptional regulation | MAPK and NFAT pathways |
| Cytoskeletal reorganization | Actin dynamics |
PLCG2 is expressed in:
| Approach | Status | Description |
|---|---|---|
| PLCG2 inhibitors | Research | ATP-competitive inhibitors |
| Immunomodulation | Research | Targeting microglial PLCG2 |
| Gene therapy | Experimental | Modulating expression |
Watson SP, et al. (1998). Structure and function of PLC-gamma. Adv Enzyme Regul 38:299-312. PMID:9820043
Katan M. (1998). New insights into the structure and function of PLC-gamma. Semin Cell Dev Biol 9(2):167-171. PMID:9591414
Mao JH, et al. (2019). PLCG2 as a risk gene in Alzheimer's disease. Nat Neurosci 22(1):29-38. PMID:30559472
The study of Plcg2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Watson SP, et al. (1998). Structure and function of PLC-gamma. Adv Enzyme Regul 38:299-312. PMID:9820043
[2] Katan M. (1998). New insights into the structure and function of PLC-gamma. Semin Cell Dev Biol 9(2):167-171. PMID:9591414
[3] Mao JH, et al. (2019). PLCG2 as a risk gene in Alzheimer's disease. Nat Neurosci 22(1):29-38. PMID:30559472
[4] Lattore L, et al. (2020). PLCG2 variants in Alzheimer's disease. Nat Genet 52(1):7-9. PMID:31852800
[5] Sims R, et al. (2017). Rare coding variants in PLCG2 associated with Alzheimer's disease. Nat Neurosci 20(8):1075-1085. PMID:28628103